Breast Cancer DX: Is there a Market Here?
Executive Summary
The discovery of a gene associated with hereditary breast cancer opens up the potential for widespread predisposition-to-disease testing. But other areas of breast cancer diagnostics are also seeing a flurry of activity, notably new tumor markers for detecting recurrence and prognosis of disease.